Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLOFITAMAB-GXBM for Lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where GLOFITAMAB-GXBM was used for Lymphoma.

Most Reported Side Effects for GLOFITAMAB-GXBM

Side Effect Reports % Deaths Hosp.
Cytokine release syndrome 107 21.5% 16 41
Disease progression 68 13.7% 40 13
Off label use 68 13.7% 9 17
Death 67 13.5% 67 6
Pyrexia 45 9.0% 12 8
No adverse event 28 5.6% 0 0
Immune effector cell-associated neurotoxicity syndrome 25 5.0% 13 18
Infection 20 4.0% 11 13
Pneumonia 14 2.8% 9 3
Condition aggravated 12 2.4% 11 0
Covid-19 10 2.0% 4 3
Drug ineffective 10 2.0% 4 2
Sepsis 10 2.0% 5 5
Diffuse large b-cell lymphoma recurrent 9 1.8% 0 1
Dyspnoea 9 1.8% 2 5

Other Indications for GLOFITAMAB-GXBM

Diffuse large b-cell lymphoma (313) Product used for unknown indication (55) Diffuse large b-cell lymphoma refractory (38) B-cell lymphoma (20) Mantle cell lymphoma (18) Diffuse large b-cell lymphoma recurrent (10) Follicular lymphoma (7) Burkitt's lymphoma (6) Lymphoma transformation (5)

Other Drugs Used for Lymphoma

RITUXIMAB (3,142) CYCLOPHOSPHAMIDE (1,729) VINCRISTINE (1,452) LENALIDOMIDE (1,427) DOXORUBICIN (1,420) ETOPOSIDE (915) IBRUTINIB (896) PREDNISONE (672) METHOTREXATE (647) CYTARABINE (645)

Related Pages

GLOFITAMAB-GXBM Full Profile All Lymphoma Drugs GLOFITAMAB-GXBM Demographics GLOFITAMAB-GXBM Timeline